| Date Filed | Type | Description |
| 08/09/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 05/10/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 04/05/2023 |
4
| BOSCH MARNIX L (Chief Technical Officer) has filed a Form 4 on NORTHWEST BIOTHERAPEUTICS INC|
Txns:
| Granted 119,355 shares
@ $0.25, valued at
$29.8k
|
|
| 04/05/2023 |
4
| BOYNTON ALTON L (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on NORTHWEST BIOTHERAPEUTICS INC|
Txns:
| Gifted 6,794,191 options
@ $0.35, valued at
$2.4M
|
|
| 03/08/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 02/28/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 02/07/2023 |
5
| BOYNTON ALTON L (CHIEF SCIENTIFIC OFFICER) has filed a Form 5 on NORTHWEST BIOTHERAPEUTICS INC |
| 01/13/2023 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits ... |
| 01/06/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 12/23/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 12/16/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 11/25/2022 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 11/09/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 10/26/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 10/18/2022 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 08/09/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 07/26/2022 |
8-K
| Quarterly results |
| 07/14/2022 |
UPLOAD
| Form UPLOAD - SEC-generated letter: |
| 06/30/2022 |
10-K/A
| Annual Report for the period ended December 31, 2021 [amend] |
| 06/28/2022 |
UPLOAD
| Form UPLOAD - SEC-generated letter: |
| 05/09/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 05/02/2022 |
10-K/A
| Annual Report for the period ended December 31, 2021 [amend] |
| 03/01/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 11/29/2021 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 11/15/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
| 08/16/2021 |
10-Q
| Quarterly Report for the period ended June 30, 2021 |
| 05/24/2021 |
8-K
| Quarterly results |
| 05/17/2021 |
10-Q
| Quarterly Report for the period ended March 31, 2021 |
| 04/16/2021 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/31/2021 |
10-K
| Annual Report for the period ended December 31, 2020 |
| 03/05/2021 |
8-K
| Quarterly results |
| 01/26/2021 |
8-K
| Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits Interactive Data |
|